Insider Trading February 26, 2026

IES Holdings Director Disposes $2.5M in Stock Amid Mixed Quarterly Results

Todd M. Cleveland sold 4,896 IESC shares over three trading days as the company reports revenue beats but an earnings shortfall for Q1 fiscal 2026

By Priya Menon IESC
IES Holdings Director Disposes $2.5M in Stock Amid Mixed Quarterly Results
IESC

Todd M. Cleveland, a director at IES Holdings, Inc. (NASDAQ: IESC), sold 4,896 shares of common stock between February 24 and February 26, 2026, for roughly $2.5 million. The trades came while the stock trades at $515.05, up 177% over the prior year; recent company results showed a revenue beat but an earnings miss for the first quarter of fiscal 2026.

Key Points

  • Director Todd M. Cleveland sold 4,896 IES Holdings shares for about $2.5 million between February 24-26, 2026.
  • IESC shares trade at $515.05, up 177% over the past year; InvestingPro flags a P/E of 29.94 and classifies the company’s financial health as "GREAT."
  • Company results for Q1 fiscal 2026 featured an earnings miss but revenue above forecasts; Freedom Capital Markets raised its price target to $458 and maintained a Buy rating, citing a stronger position in non-residential segments.

Overview

Director Todd M. Cleveland of IES Holdings, Inc. (NASDAQ: IESC) completed sales of 4,896 shares of the company’s common stock between February 24 and February 26, 2026, generating approximately $2.5 million in proceeds. Transaction prices ranged from $510.26 to $521.00. These insider sales occurred while IESC shares were trading at $515.05, a level that represents a 177% gain over the last 12 months.

Transaction details

The disposition was executed across three days and multiple price points. On February 24, Cleveland sold 181 shares at $520.25 apiece. On February 25, the filings report sales of 2,144 shares in the $510.00 to $510.99 range, 600 shares between $511.00 and $511.80, and 375 shares at $521.00. On February 26, Cleveland sold 714 shares in a $510.00 to $510.97 band, 586 shares within $511.00 to $511.25, 100 shares at $512.00, and 300 shares in the $513.64 to $513.84 range. After these transactions, Cleveland directly holds 80,817 shares of IES Holdings.

Valuation and analyst context

At current prices, InvestingPro analysis identifies IESC as carrying a price-to-earnings ratio of 29.94 and notes the stock appears overvalued at these levels. The platform additionally assigns IES Holdings a "GREAT" financial health score and lists 13 supplementary InvestingPro Tips for users seeking a deeper look at the company’s metrics.

Recent corporate results and analyst action

In its latest reporting, IES Holdings disclosed fiscal first-quarter 2026 results that fell short of analyst expectations on the earnings line, even as revenue outperformed forecasts. In response to company performance and outlook, Freedom Capital Markets raised its price target on IES Holdings from $440 to $458 and maintained a Buy rating, citing an improving position in non-residential segments.

Governance and shareholder votes

IES Holdings also completed its 2026 Annual Stockholders Meeting. Shareholders elected all company nominees to the board of directors and ratified the engagement of Ernst & Young LLP as the company’s independent public accountants for the fiscal year ending September 30, 2026. In addition, shareholders approved, on an advisory basis, the compensation of the company’s named executive officers.

What this reflects

The disclosed insider sale, contemporaneous valuation commentary and mixed quarterly results paint a multifaceted picture of IES Holdings’ current profile: a stock that has posted outsized calendar returns over 12 months, a valuation flagged as rich by InvestingPro metrics, recent revenue strength alongside an earnings shortfall, and continued institutional endorsement via an upgraded price target from Freedom Capital Markets.

Risks

  • Earnings shortfall: The company’s Q1 fiscal 2026 earnings missed analyst expectations, which can pressure investor sentiment in the industrials and related markets.
  • Valuation concerns: InvestingPro’s assessment that the stock appears overvalued with a P/E of 29.94 highlights a valuation risk for investors at current price levels.
  • Perception from insider selling: The director’s $2.5 million sale may affect market perception of the stock, potentially increasing short-term volatility in the industrials and construction-related equities.

More from Insider Trading

BlackRock Senior Managing Director Disposes $2.58M in Company Shares Feb 26, 2026 Vertex EVP Sells $126K in Stock as Company Nears 52-Week High Feb 26, 2026 Vertex Executive Sells Nearly $1.6M in Stock Across Two Days Feb 26, 2026 Krystal Biotech Director Executes $10.1M Stock Sale, Exercises Options Under 10b5-1 Plan Feb 26, 2026 Vertex Executive Sells $2.39M in Stock as Company Nears 52-Week High Feb 26, 2026